Decrypt
A Phase 3 win against the standard of care sent the biotech's shares up 131% and left short sellers down $4.8 billion.
Related articles
-
BofA Elevates Taiwan Semiconductor (TSM) Price Target to $590 Amid US Expansion Success
Blocknomi Published 18.08.2026 17:13
-
XRP 2026 Futures Axed as BitMEX Shuts Down; Coinbase Launches Free US Stocks in UK; Bitcoin Strategy Raises $15 Billion via ChatGPT: Michael Saylor — Morning Crypto Report
U.Today Published 06.08.2026 12:50
-
12 Nasdaq Stocks Doubled in 2026, But None Are Magnificent Seven
BeInCrypto Published 11.08.2026 05:25
-
Michael Saylor Identifies the Next Billion-Dollar Finance Opportunity
Bitcoin.com Published 08.08.2026 23:50
-
Pi Network price forms a double bottom, can it break out ahead of the Protocol 26 upgrade?
Crypto.News Published 06.08.2026 13:30
-
Semiconductor Rally Defies Market Weakness as Retail Earnings Loom
Blocknomi Published 17.08.2026 16:10
-
Ethereum Hegotá Puts Frame Transactions and Privacy on the 2027 Roadmap
Crypto Daily Published 18.08.2026 17:11
-
Circle Sets September 16 Arc Mainnet Launch With Institutional Validators
Crypto Daily Published 06.08.2026 07:51